Immunomodulating potential of supplementation with probiotics: A dose-response study in healthy young adults

FEMS Immunology and Medical Microbiology

Volumn 47, Issue 3, 2006, Pages 380-390

  Christensen, Hanne Risager ^a   Larsen, Charlotte Nexmann ^b   Kæstel, Pernille ^c   Rosholm, Lisbeth Buus ^a   Sternberg, Claus ^a   Michaelsen, Kim Fleischer ^c   Frøkiær, Hanne ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b CHR HANSEN A S   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Dose response; Healthy human adults; Immunomodulation; Probiotic

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN A; INTERLEUKIN 10; PLACEBO; PROBIOTIC AGENT;

ADULT; ARTICLE; BIFIDOBACTERIUM ANIMALIS; CLINICAL TRIAL; COLONY FORMING UNIT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FECES ANALYSIS; FEMALE; HUMAN; IMMUNOMODULATION; LACTOBACILLUS PARACASEI; LEUKOCYTE; MALE; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RANDOMIZATION; STATISTICAL SIGNIFICANCE; SUPPLEMENTATION;

ADOLESCENT; ADULT; BIFIDOBACTERIUM; CYTOKINES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; LACTOBACILLUS; LYMPHOCYTE ACTIVATION; MALE; PHAGOCYTES; PHAGOCYTOSIS; PROBIOTICS;

EID: 33745850829     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2006.00109.x     Document Type: Article

References (44)

1. Abreu MT, Arnold ET, Thomas LS, Gonsky R, Zhou YH, Hu B & Arditi M (2002) TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 277: 20431-20437.
2. Arunachalam K, Gill HS & Chandra RK (2000) Enhancement of natural immune function by dietary consumption of Bifidobacterium lactis (HN019). Eur J Clin Nutr 54: 263-267.
3. Beimfohr C, Krause A, Amann R, Ludwig W & Schleifer KH (1993) In-Situ identification of lactococci, enterococci and streptococci. Syst Appl Microbiol 16: 450-456.
4. Bick RL (1993) Hematology and Clinical and Laboratory Practice. Mosby, St Louis.
5. Cebra JJ (1999) Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69: 1046S-1051S.
6. Chiang BL, Sheih YH, Wang LH, Liao CK & Gill HS (2000) Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur J Clin Nutr 54: 849-855.
7. de Vrese M, Reutenberg P, Laue C, Koopmans M, Herremans T & Schrezenmeir J (2004) Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr 541: 1-8.
8. Donnet-Hughes A, Rochat F, Serrant P, Aeschlimann JM & Schiffrin EJ (1999) Modulation of nonspecific mechanisms of defense by lactic acid bacteria: effective dose. J Dairy Sci 82: 863-869.
9. Dunne C, O'Mahony L, Murphy L, et al. (2001) In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 73: 386S-392S.
10. Fedorak RN & Madsen KL (2004) Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10: 286-299.
11. Fukushima Y, Kawata Y, Hara H, Terada A & Mitsuoka T (1998) Effect of a probiotic formula on intestinal immunoglobulin a production in healthy children. Int J Food Microbiol 42: 39-44.
12. Fukushima Y, Kawata Y, Mizumachi K, Kurisaki J & Mitsuoka T (1999) Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse. Int J Food Microbiol 46: 193-197.
13. Galdeano CM & Perdigon G (2004) Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 97: 673-681.
14. Gill HS & Rutherfurd KJ (2001a) Viability and dose-response studies on the effects of the immunoenhancing lactic acid bacterium Lactobacillus rhamnosus in mice. Br J Nutr 86: 285-289.
15. Gill HS & Rutherfurd KJ (2001b) Probiotic supplementation to enhance natural immunity in the elderly: effects of a newly characterized immunostimulatory strain Lactobacillus rhamnosus HN001 (DR20 (TM)) on leucocyte phagocytosis. Nutr Res 21: 183-189.
16. Gill HS, Rutherfurd KJ, Cross ML & Gopal PK (2001) Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 74: 833-839.
17. Guandalini S, Pensabene L, Abu Zikri M, et al. (2000) Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr 30: 54-60.
18. Guarner F & Malagelada JR (2003) Gut flora in health and disease. Lancet 361: 512-519.
19. He F, Ouwehand AC, Isolauri E, Hashimoto H, Benno Y & Salminen S (2001) Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunol Med Microbiol 30: 43-47.
20. Hebuterne X (2003) Gut changes attributed to ageing: effects on intestinal microflora. Curr Opin Clin Nutr Metabol Care 6: 49-54.
21. Holt PG & Jones CA (2000) The development of the immune system during pregnancy and early life. Allergy 55: 688-697.
22. Hung L & Bandziulus R (2005) Megabase DNA analysis: chromasomal DNA preparation, restriction, and pulsed-field electrophoresis. Promega Notes 24: 1-3.
23. Isolauri E, Arvola T, Sutas Y, Moilanen E & Salminen S (2000) Probiotics in the management of atopic eczema. Clin Exp Allergy 30: 1604-1610.
24. Jacobsen CN, Rosenfeldt NV, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M & Jakobsen M (1999) Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol 65: 4949-4956.
25. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S & Arvilommi H (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res 32: 141-144.
26. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P & Isolauri E (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
27. Kelly D & Conway S (2005) Bacterial modulation of mucosal innate immunity. Mol Immunol 42: 895-901.
28. Kirjavainen PV, Apostolou E, Arvola T, Salminen SJ, Gibson GR & Isolauri E (2001) Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease. FEMS Immunol Med Microbiol 32: 1-7.
29. Kjær TMR & Frøkiær H (2005) Dietary lectins and the immune response. Reviews in Food and Nutrition Toxicity, Vol. 4 (Preedy VR, ed), pp. 271-296. CRC Press, Boca Raton.
30. Kuisma J, Mentula S, Jarvinen H, Kahri A, Saxelin M & Farkkila M (2003) Effect of Lactobacillus rhamnosus GG on ileal pouch inflammation and microbial flora. Aliment Pharmacol Ther 17: 509-515.
31. Macpherson AJ & Uhr T (2004) Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303: 1662-1665.
32. Majamaa H, Isolauri E, Saxelin M & Vesikari T (1995) Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr 20: 333-338.
33. Malin M, Suomalainen H, Saxelin M & Isolauri E (1996) Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab 40: 137-145.
34. Mimura T, Rizzello F, Helwig U, Poggioli G, Schreiber S, Talbot IC, Nicholls RJ, Gionchetti P, Campieri M & Kamm MA (2004) Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 53: 108-114.
35. O'Garra A, Vieira PL, Vieira P & Goldfeld AE (2004) IL-10-producing and naturally occurring CD4+Tregs: limiting collateral damage. J Clin Invest 114: 1372-1378.
36. Rautava S, Kalliomaki M & Isolauri E (2002) Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against atopic disease in the infant. J Allergy Clin Immunol 109: 119-121.
37. Roller M, Pietro FA, Caderni G, Rechkemmer G & Watzl B (2004) Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br J Nutr 92: 931-938.
38. Rosenfeldt V, Michaelsen KF, Jakobsen M, Larsen CN, Moller PL, Tvede M, Weyrehter H, Valerius NH & Paerregaard A (2002) Effect of probiotic Lactobacillus strains on acute diarrhea in a cohort of nonhospitalized children attending day-care centers. Pediatr Infect Dis J 21: 417-419.
39. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH & Paerregaard A (2003) Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 111: 389-395.
40. Schiffrin EJ, Brassart D, Servin AL, Rochat F & Donnet-Hughes A (1997) Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am J Clin Nutr 66: 515S-520S.
41. Stagg AJ, Hart AL, Knight SC & Kamm MA (2003) The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria. Gut 52: 1522-1529.
42. Stahl DA, Devereux R, Amann RI, Flesher B, Lin C & Stromley J (1989) Ribosomal RNA based studies of natural microbial diversity and ecology. Recent Advances in Microbial Ecology (Hattori T, et al., eds), pp. 669-673. Japan Scientific Societies Press, Tokyo.
43. Tannock G (2002) The bifidobacterial and lactobacillus microflora of humans. Clin Rev Allergy Immunol 22: 231-253.
44. Tejada-Simon MV, Lee JH, Ustunol Z & Pestka JJ (1999) Ingestion of yogurt containing Lactobacillus acidophilus and Bifidobacterium to potentiate immunoglobulin A responses to cholera toxin in mice. J Dairy Sci 82: 649-660.